|
HS Code |
726121 |
| Product Name | Boc-L-Cyclopropylglycine |
| Cas Number | 135072-62-9 |
| Molecular Formula | C10H17NO4 |
| Molecular Weight | 215.25 |
| Synonyms | tert-Butoxycarbonyl-L-cyclopropylglycine |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Melting Point | 88-92°C |
| Storage Temperature | 2-8°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Smiles | CC(C)(C)OC(=O)N[C@@H](C1CC1)C(=O)O |
| Chirality | L-configuration |
| Use | Protected amino acid for peptide synthesis |
As an accredited Boc-L-Cyclopropylglycine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-L-Cyclopropylglycine is packaged in a sealed 25g amber glass bottle, labeled with product details and safety information. |
| Shipping | Boc-L-Cyclopropylglycine is shipped in secure, airtight containers to ensure stability and prevent contamination. The packaging complies with international transport regulations for chemicals, including labeling for identification and hazard classification. It is typically dispatched at ambient temperature, with expedited shipping available upon request to maintain compound integrity during transit. |
| Storage | **Boc-L-Cyclopropylglycine** should be stored in a cool, dry, and well-ventilated area, away from sources of moisture and direct sunlight. Keep the container tightly closed when not in use. Store at 2-8°C (refrigerated conditions) to maintain stability. Avoid exposure to incompatible materials and ensure appropriate labeling for chemical identification and hazard communication. |
Applications of Boc-L-Cyclopropylglycine in Industrial ManufacturingBoc-L-Cyclopropylglycine serves as a specialized intermediate in industrial chemistry, supporting advanced synthesis pathways in both pharmaceutical and peptide production. Our manufacturing process ensures consistent purity and quality for scale-up requirements in regulated downstream applications. 1. Pharmaceutical API Intermediate SynthesisBoc-L-Cyclopropylglycine acts as a non-proteinogenic amino acid building block during the multi-step synthesis of innovative active pharmaceutical ingredients, especially in the development of clinical candidates targeting metabolic disorders or neurological diseases. Manufacturers integrate this compound at the skeleton formation stage, taking advantage of its cyclopropane unit to impart structural rigidity and increase metabolic stability of final APIs. Downstream QC teams monitor chirality and residual solvents according to batch standards set by leading authorities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptide Drug Development and ManufacturingPeptide manufacturers leverage Boc-L-Cyclopropylglycine for the incorporation of conformationally constrained residues within custom synthesis programs. The cyclopropane-substituted glycine increases biological stability and binding affinity of peptides, making it a key component in analogs and peptidomimetics developed for pharmaceutical and biotechnological products. Large-scale facilities handle this raw material under controlled humidity and inert gas to maintain quality, tracking batch genealogy as per cGMP traceability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Custom Synthesis for Preclinical Contract ResearchCROs and research laboratories specify Boc-L-Cyclopropylglycine as a key fragment in the tailored synthesis of molecular probes and novel compound classes for preclinical screening. The reagent’s role is to introduce cyclopropyl structural motifs, which modify binding kinetics and target selectivity, thus enhancing downstream SAR studies. Our production controls supply consistency and batch documentation, supporting regulatory requirements in international research collaborations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis of Stable Isotope-Labeled StandardsBoc-L-Cyclopropylglycine enables the creation of stable isotope-labeled amino acids for analytical applications in bioanalytical and forensic laboratories. Isotope enrichment commonly involves tritiated or carbon-13/15N labeled versions synthesized via established routes, where our raw material supplies the required backbone precursor. Controlled labeling methods ensure batch reproducibility for downstream quantitation and calibration standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-L-Cyclopropylglycine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a manufacturer with years immersed in peptide chemistry, I see Boc-L-Cyclopropylglycine as a backbone for research and development. This compound, recognized by model number CAS 161558-41-4, fills an essential role in complex molecule assembly. Laboratories and pharma teams working with difficult peptide sequences often reach for this intermediate after encountering roadblocks with other protected amino acids. Its stability, predictable reactivity, and solid handling characteristics make it a reliable starting point for new projects.
Working with Boc-L-Cyclopropylglycine in our facility means tuning each batch to meet strict benchmarks. We maintain purity consistently above 98% by HPLC. Every drum, every small vial leaving our lines faces checks for moisture, chromatographic profile, and optical rotation. Chemists depend on clear, crystalline material. Even a half-percent deviation throws off a solid-phase process, causing unwanted byproducts or yield losses. Over the years, we’ve built systems so that each lot shows a white, odorless solid, stable under normal dry storage, and easily weighed and transferred.
Anyone handling Boc-L-Cyclopropylglycine in a synthetic pathway will notice its tidy solubility profile: it dissolves well in most organic solvents common to peptide coupling. Chloroform, methanol, acetonitrile—all familiar territory. It stays stable for long periods when stored under nitrogen and away from sunlight, resisting the kind of hydrolysis that plagues many other protected amino acids. In our practice, shelf life often extends past two years with no degradation in performance.
As custom research requests grow more advanced each year, so does the demand for non-standard amino acids. Boc-L-Cyclopropylglycine consistently sits at the center of such work. The cyclopropyl ring introduces rigidity that native glycine lacks, so medicinal chemists use this building block to nudge biological properties or create molecules with novel twists. Reliable supply helps our customers avoid interruptions as patent timelines tighten and go-to-market schedules accelerate.
Compared to other cyclopropylglycine derivatives—whether Fmoc-protected or t-butyl esters—Boc-L-Cyclopropylglycine has its own character. The Boc protection group handles moderate acids with ease, letting researchers deploy diverse deprotection methods without risking the core structure. Thermal stability proves critical when moving from lab to large-scale reactors. Years ago, I watched a team struggle with byproducts from an Fmoc-protected analog under routine coupling; the Boc version sidestepped those impurities, keeping the end product clean and the purification process straightforward.
Reliable upstream materials decide the fate of downstream synthesis. Early mistakes compound in costly ways. We routinely work with clients who hit barriers in multi-step routes using lower-grade intermediates. Boc-L-Cyclopropylglycine free from side-products, delivered as promised, often resets stalled R&D programs. Our process avoids chromatographic tailing and rogue rotamers that complicate assemblies. Purity checks at every step, precise moisture control, and validated packing methods protect both the chemistry and the schedule.
My perspective comes not from paperwork but from mixing kettles, filtration lines, and the repeated challenge of handling tricky amino acid derivatives. Boc-L-Cyclopropylglycine earns its reputation because its crystals handle predictably—no caking, no static issues, and minimal fines in the air. Waste minimization also matters to us. We optimize synthesis to skip unnecessary steps and use solvent recovery, meaning less material ends up in non-recoverable waste streams. Chemical manufacturers take stewardship seriously, and our approach puts safety and environmental impact on par with technical purity.
Any company can list product specifications, but those only matter if a compound performs in real-world processes. Our experience with Boc-L-Cyclopropylglycine in peptide coupling bears this out. It enables peptide backbone designs that resist enzymatic cleavage, so the resulting analogs show better metabolic profiles. The compound activates smoothly with most coupling agents, including EDC, HATU, and DIC, delivering strong conversions even at modest scales. I recall assisting a development chemist in troubleshooting a challenging ligation: using this material, yields doubled and purifications required fewer passes.
Our production teams receive regular questions about which protecting group best fits a workflow. Boc-L-Cyclopropylglycine gives flexibility when mild acidic cleavage is desirable, avoiding the complications that Fmoc deprotection can introduce in certain solvent systems. Side-chain functionality stays untouched during elongation; process chemists prefer the avoidance of base-induced rearrangement they sometimes see with Fmoc. For parallel synthesis setups or scale-ups, the Boc derivative often slides into established automation, reducing labor and analytical cycles.
In precise peptide manufacturing, stereocontrol decides more than quality—it makes the difference between progress and rebuilding from scratch. Our batches of Boc-L-Cyclopropylglycine maintain enantiomeric excesses verified at every stage. As requests for chiral purity intensify for active pharmaceutical ingredients or research peptides, our experience working with optical rotation and chiral chromatography pays off. Small impurities, if unchecked, can amplify downstream, producing compounds with altered bioactivity. Consistent stereochemistry spares clients from repeating months of work.
Moving from gram-scale to hundreds of kilograms brings a unique set of challenges. Thermal control, product isolation, and reactive intermediate management become daily concerns. Our team developed protocols that balance solvent usage, temperature profiles, and in-process analytics to sustain yield and purity as output increases. I remember early years handling five-liter glassware filled with Boc-L-Cyclopropylglycine, fine-tuning each process step under watchful eyes. Now, with seamless scale-up, kilo-lots roll out without sacrificing integrity.
Anyone manufacturing Boc-L-Cyclopropylglycine must respect its chemical profile. Dust control, containment, and safe solvent handling stack up behind every successful campaign. Training production staff to use proper personal protective equipment and maintain equipment hygiene goes beyond regulatory compliance; it saves lives. Our facility upgrades include localized extraction, spill management kits, and routine drills. Every near-miss in our early history led to a safer process today.
Industries pushing into novel peptide therapeutics, small-molecule drugs, and chemical biology constructs repeatedly query us for recommendations. We see Boc-L-Cyclopropylglycine moving to the center of next-generation research, especially where cyclopropyl motifs change molecular properties in ways that matter for absorption and resistance to degradation. As this field matures, new modification strategies will build on earlier work. Our presence at every stage—from sourcing raw glycine through to the boxed finished intermediate—gives both flexibility for custom requirements and peace of mind about consistent quality.
Decisions between Boc, Fmoc, or unprotected variants depend on more than literature—real project timelines, waste streams, and purification steps all steer product choice. In our plant, switching clients from Fmoc-L-Cyclopropylglycine to the Boc variety cut purification times by a quarter due to less stubborn chromatography. Every batch produced a tighter main peak in HPLC traces, improving documentation for regulatory filings. Feedback from partners in Japan and North America confirmed that the switch translated to shorter project delivery and less downtime for high-throughput laboratories.
Modern manufacturers carry a responsibility not only to the compound but to the communities and environments intersecting with it. We optimize Boc-L-Cyclopropylglycine production schedules to minimize solvent waste and energy consumption. Heat recovery, water recirculation, and thorough staff training cut emissions and hazard potential. Every improvement in crystal isolation, each gain in process yield, lowers the overall environmental footprint. These steps align with growing client expectations about green chemistry and make routine compliance tasks less burdensome.
We’ve watched research trends shift, with project managers now prioritizing both technical specs and supplier stability. Boc-L-Cyclopropylglycine becomes a linchpin for start-to-finish reliability. Inventory management, rapid delivery windows, lot traceability, and batch-to-batch consistency matter as much as purity. Our practice includes safety stock, flexible packaging, and supply chain safeguards built after years experiencing customs delays and force majeure events. This way, customers can focus on innovation, trusting that sourcing headaches won’t interrupt their timelines.
Anyone integrating Boc-L-Cyclopropylglycine into a workflow will want to know how it interacts under various conditions. In our own testing, the compound shows low risk of racemization during standard coupling—important for those building large, chiral peptides. Boc removal with TFA or HCl proceeds cleanly, with minimal formation of t-butyl cations or related carbocation-derived side-products. In scale-up or flow chemistry setups, the predictable melting point and low tendency toward oiling out help avoid stoppages and rework. These are features developed not from textbook abstracts but real-world performance data logged over dozens of client cases.
For many customers, Boc-L-Cyclopropylglycine opens doors to analogs unattainable with standard glycine or alanine derivatives. Rigidification of peptidic backbones, fine-tuning of turns in biomimetic macrolactams, or constructing stable enzyme inhibitors—all benefit from the cyclopropyl moiety. Our technical support team, staffed by chemists who spent years elbow-deep in synthesis, works with partners on custom adaptations. Real solutions grow from direct communication, detailed batch records, and seeing the obstacles that face those on the lab bench.
No process ever remains static. As feedback pours in from pharmaceutical pioneers and academic labs using Boc-L-Cyclopropylglycine in unorthodox ways, we adapt. Small tweaks in crystallization, improvements in drying, and updated purity assessment protocols all come from hearing what clients need. Years in the business taught us that success is measured by repeat orders and word-of-mouth recommendations, not just the number on a COA.
Boc-L-Cyclopropylglycine embodies much of what modern chemical manufacturing stands for: precision, safety, adaptability, and partnership. While competitors may talk of supply, our perspective keeps attention on real-world issues—batch reproducibility, safety, and practical guidance. Whether for large commercial batches or single-gram solutions in scale-ups, our team treats each request as a chance to advance both science and trust. Each kilogram shipped represents hands-on care and decades of accumulated knowledge poured into getting synthesis right the first time.